The Relative Strength (RS) Rating for Schrodinger climbed into a new percentile Tuesday, with an increase from 77 to 83.
This unique rating tracks technical performance by using a 1 (worst) to 99 (best) score that shows how a stock's price action over the last 52 weeks matches up against that of all other stocks.
Decades of market research shows that the stocks that go on to make the biggest gains tend to have an RS Rating north of 80 as they begin their biggest climbs.
Hone Your Stock-Picking Skills By Focusing On These Factors
While Schrodinger is not near an ideal buying range right now, see if it manages to form and break out of a proper consolidation.
The company posted 0% earnings growth in its most recent report, while sales growth came in at 19%.
Schrodinger earns the No. 14 rank among its peers in the Medical-Research Equipment/Services industry group. Veracyte, Natera and Medpace Holdings are among the top 5 highly rated stocks within the group.
This article was created automatically with Stats Perform's Wordsmith software using data and article templates supplied by Investor's Business Daily. An IBD journalist may have edited the article.
RELATED:
IBD Stock Rating Upgrades: Rising Relative Strength
Why Should You Use IBD's Relative Strength Rating?
How Relative Strength Line Can Help You Judge A Stock
Ready To Grow Your Investing Skills? Join An IBD Meetup Group!
